J&J offers to buy ITCI for $14.6 billion. LLY announces disappointing preliminary sales numbers for the fourth quarter.

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...

Johnson amp Johnson JampJ the American multinational pharmaceutical biotechnology and medical technologies corporation agreed to acquire men ...

A man accused of killing his wife and stepson in Henderson was found competent by a judge Wednesday, which means his case ...

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a clinical-stage neuropsychiatry company, summarized its 2024 accomplishments and detailed upcoming 2025 m ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a neuropsychiatry platform company, announced its first strategic partnership agreement (“SPA”) with Segal Trials as part of its multinational pivotal Phase 3 ...

Other medication options for late-life GAD ... and serotonin norepinephrine reuptake inhibitors are indicated for generalized anxiety disorder. Cognitive behavioural therapy is a gold standard ...

Questions over the extent to which animals can experience mental illness have existed for centuries. Though researchers and ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...